Anna Vilgelm
-
Potential second-line melanoma treatment identified
A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients. Read MoreAug 15, 2019
-
Breast cancer program lands new research grants
Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients. Read MoreMar 23, 2017
-
Combining treatments for melanoma
Combining therapies for melanoma that induce cell senescence and that activate the immune response may improve outcomes for patients. Read MoreFeb 18, 2016
-
Study tracks combination therapy to treat melanoma
Melanoma is the most lethal form of skin cancer, with high mortality rates. While new drugs have been approved to treat the disease, patients nearly always develop resistance to the therapies and the cancer advances. Read MoreJan 8, 2015